• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法匹拉韦治疗可延长艾比湖病毒感染致死性BALB/c小鼠模型的生存期。

Favipiravir Treatment Prolongs Survival in a Lethal BALB/c Mouse Model of Ebinur Lake Virus Infection.

作者信息

Geng Jingke, Ren Nanjie, Yang Cihan, Wang Fei, Huang Doudou, Rodriguez Sergio, Yuan Zhiming, Xia Han

机构信息

Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430200, China.

University of Chinese Academy of Sciences, Beijing 101408, China.

出版信息

Viruses. 2024 Apr 18;16(4):631. doi: 10.3390/v16040631.

DOI:10.3390/v16040631
PMID:38675972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11054260/
Abstract

is the largest and most diverse genus in the family Peribunyaviridae. Orthobunyaviruses are widely distributed globally and pose threats to human and animal health. Ebinur Lake virus (EBIV) is a newly classified Orthobunyavirus detected in China, Russia, and Kenya. This study explored the antiviral effects of two broad-spectrum antiviral drugs, favipiravir and ribavirin, in a BALB/c mouse model. Favipiravir significantly improved the clinical symptoms of infected mice, reduced viral titer and RNA copies in serum, and extended overall survival. The median survival times of mice in the vehicle- and favipiravir-treated groups were 5 and 7 days, respectively. Favipiravir significantly reduced virus titers 10- to 100-fold in sera at all three time points compared to vehicle-treated mice. And favipiravir treatment effectively reduced the virus copies by approximately 10-fold across the three time points, relative to vehicle-treated mice. The findings expand the antiviral spectrum of favipiravir for orthobunyaviruses in vivo.

摘要

是布尼亚病毒科中最大且最多样化的属。正布尼亚病毒在全球广泛分布,对人类和动物健康构成威胁。艾比湖病毒(EBIV)是一种在中国、俄罗斯和肯尼亚检测到的新分类正布尼亚病毒。本研究在BALB/c小鼠模型中探讨了两种广谱抗病毒药物法匹拉韦和利巴韦林的抗病毒效果。法匹拉韦显著改善了感染小鼠的临床症状,降低了血清中的病毒滴度和RNA拷贝数,并延长了总体生存期。溶剂对照组和法匹拉韦治疗组小鼠的中位生存时间分别为5天和7天。与溶剂对照组小鼠相比,法匹拉韦在所有三个时间点均使血清中的病毒滴度显著降低了10至100倍。并且与溶剂对照组小鼠相比,法匹拉韦治疗在三个时间点均有效地将病毒拷贝数降低了约10倍。这些发现扩展了法匹拉韦在体内对正布尼亚病毒的抗病毒谱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a8/11054260/65976c6728f8/viruses-16-00631-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a8/11054260/91350b068999/viruses-16-00631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a8/11054260/89894dc212c9/viruses-16-00631-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a8/11054260/c88b72583dec/viruses-16-00631-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a8/11054260/65976c6728f8/viruses-16-00631-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a8/11054260/91350b068999/viruses-16-00631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a8/11054260/89894dc212c9/viruses-16-00631-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a8/11054260/c88b72583dec/viruses-16-00631-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a8/11054260/65976c6728f8/viruses-16-00631-g004.jpg

相似文献

1
Favipiravir Treatment Prolongs Survival in a Lethal BALB/c Mouse Model of Ebinur Lake Virus Infection.法匹拉韦治疗可延长艾比湖病毒感染致死性BALB/c小鼠模型的生存期。
Viruses. 2024 Apr 18;16(4):631. doi: 10.3390/v16040631.
2
Efficient rescue of a newly classified Ebinur lake orthobunyavirus with GFP reporter and its application in rapid antiviral screening.利用 GFP 报告基因有效拯救一种新分类的艾比湖 orthobunyavirus 及其在快速抗病毒筛选中的应用。
Antiviral Res. 2022 Nov;207:105421. doi: 10.1016/j.antiviral.2022.105421. Epub 2022 Sep 21.
3
Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.利巴韦林不会增强非人类灵长类动物中抗埃博拉病毒药物法匹拉韦的抗病毒活性。
Antiviral Res. 2020 May;177:104758. doi: 10.1016/j.antiviral.2020.104758. Epub 2020 Mar 2.
4
Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.法匹拉韦(T-705)可预防超急性裂谷热病毒感染,并减少利巴韦林治疗时出现的迟发性神经疾病。
Antiviral Res. 2014 Apr;104:84-92. doi: 10.1016/j.antiviral.2014.01.016. Epub 2014 Jan 31.
5
Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.法匹拉韦(T-705)而非利巴韦林可有效抑制两种不同株系的克里米亚-刚果出血热病毒在小鼠体内的复制。
Antiviral Res. 2018 Sep;157:18-26. doi: 10.1016/j.antiviral.2018.06.013. Epub 2018 Jun 21.
6
Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin.用马拉韦罗或利巴韦林治疗的非人类灵长类动物中的拉萨病毒动力学。
PLoS Comput Biol. 2021 Jan 7;17(1):e1008535. doi: 10.1371/journal.pcbi.1008535. eCollection 2021 Jan.
7
Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.法匹拉韦单独及与利巴韦林联合在致死性、免疫健全拉沙热小鼠模型中的疗效
J Infect Dis. 2016 Mar 15;213(6):934-8. doi: 10.1093/infdis/jiv522. Epub 2015 Nov 3.
8
Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.在克里米亚-刚果出血热小鼠模型中对利巴韦林、阿比多尔和T-705(法匹拉韦)抗病毒疗效的评估。
PLoS Negl Trop Dis. 2014 May 1;8(5):e2804. doi: 10.1371/journal.pntd.0002804. eCollection 2014 May.
9
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections.法匹拉韦,一种针对危及生命的 RNA 病毒感染的抗流感药物。
Pharmacol Ther. 2020 May;209:107512. doi: 10.1016/j.pharmthera.2020.107512. Epub 2020 Feb 22.
10
The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.广谱抗病毒药物法匹拉韦可在疾病发作后保护豚鼠免受致死性拉沙病毒感染。
Sci Rep. 2015 Oct 12;5:14775. doi: 10.1038/srep14775.

引用本文的文献

1
A cap-dependent endonuclease inhibitor acts as a potent antiviral agent against La Crosse virus infection.一种帽依赖性核酸内切酶抑制剂可作为抗拉克罗斯病毒感染的强效抗病毒剂。
Antimicrob Agents Chemother. 2025 Sep 3;69(9):e0018625. doi: 10.1128/aac.00186-25. Epub 2025 Jul 23.

本文引用的文献

1
Laboratory diagnosis of CNS infections in children due to emerging and re-emerging neurotropic viruses.儿童中枢神经系统感染的新兴和重现神经嗜性病毒的实验室诊断。
Pediatr Res. 2024 Jan;95(2):543-550. doi: 10.1038/s41390-023-02930-6. Epub 2023 Dec 2.
2
Development and evaluation of RT-qPCR assays for two neglected orthobunyaviruses: Oya virus and Ebinur Lake virus.两种被忽视的正布尼亚病毒(Oya 病毒和伊宁市 Lake 病毒)的 RT-qPCR 检测方法的建立与评估。
Virus Res. 2024 Jan 2;339:199265. doi: 10.1016/j.virusres.2023.199265. Epub 2023 Nov 16.
3
Bunyavirales: Scientific Gaps and Prototype Pathogens for a Large and Diverse Group of Zoonotic Viruses.
布尼亚病毒目:一大类人畜共患病病毒的科学空白和原型病原体。
J Infect Dis. 2023 Oct 18;228(Suppl 6):S376-S389. doi: 10.1093/infdis/jiac338.
4
Annual (2023) taxonomic update of RNA-directed RNA polymerase-encoding negative-sense RNA viruses (realm : kingdom : phylum ).年度(2023)RNA 指导的 RNA 聚合酶编码负义 RNA 病毒(领域:界:门)分类学更新。
J Gen Virol. 2023 Aug;104(8). doi: 10.1099/jgv.0.001864.
5
Favipiravir and Ribavirin protect immunocompetent mice from lethal CCHFV infection.法匹拉韦和利巴韦林可保护免疫功能正常的小鼠免受致死性克里米亚-刚果出血热病毒感染。
Antiviral Res. 2023 Oct;218:105703. doi: 10.1016/j.antiviral.2023.105703. Epub 2023 Aug 21.
6
Immunocompetent hamsters as a model for orthobunyavirus-induced neuroinvasion and neuropathology.免疫功能正常的仓鼠作为正呼肠孤病毒诱导的神经入侵和神经病理学模型。
PLoS Negl Trop Dis. 2023 May 26;17(5):e0011355. doi: 10.1371/journal.pntd.0011355. eCollection 2023 May.
7
Accelerating antiviral drug discovery: lessons from COVID-19.加速抗病毒药物研发:COVID-19 的经验教训。
Nat Rev Drug Discov. 2023 Jul;22(7):585-603. doi: 10.1038/s41573-023-00692-8. Epub 2023 May 12.
8
2022 taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales.2022 年门 Negarnaviricota(Riboviria:Orthornavirae)的分类学更新,包括大目 Bunyavirales 和 Mononegavirales。
Arch Virol. 2022 Dec;167(12):2857-2906. doi: 10.1007/s00705-022-05546-z.
9
Efficient rescue of a newly classified Ebinur lake orthobunyavirus with GFP reporter and its application in rapid antiviral screening.利用 GFP 报告基因有效拯救一种新分类的艾比湖 orthobunyavirus 及其在快速抗病毒筛选中的应用。
Antiviral Res. 2022 Nov;207:105421. doi: 10.1016/j.antiviral.2022.105421. Epub 2022 Sep 21.
10
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.非人类灵长类动物中珐匹拉韦对寨卡病毒和 SARS-CoV-2 病毒的抗病毒疗效。
Nat Commun. 2022 Aug 30;13(1):5108. doi: 10.1038/s41467-022-32565-w.